Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bristol Myers Squibb : Assigned Patent

07/25/2014 | 07:18am US/Eastern

By Targeted News Service

ALEXANDRIA, Va., July 25 -- Bristol-Myers Squibb, Princeton, New Jersey, has been assigned a patent (8,785,398) developed by four co-inventors for the "methods of treatment using CTLA4 mutant molecules." The co-inventors are Robert James Peach, San Diego, Joseph Naemura, Bellevue, Washington, Peter S. Linsley, Seattle, and Jurgen Bajorath, Bonn, Germany.

The patent application was filed on Oct. 20, 2011 (13/277,425). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=87,85,398.PN.&OS=PN/87,85,398&RS=PN/87,85,398

Written by Sudarshan Harpal; edited by Jaya Anand.

SH0725JA0725-1039881

(c) 2014 Targeted News Service

React to this article
Latest news on BRISTOL-MYERS SQUIBB CO
04/01 BRISTOL-MYERS SQUIBB CO : ex-dividend day
03/31 BRISTOL MYERS SQUIBB : Purchases Exclusive License from Novo Nordisk
03/27 BRISTOL MYERS SQUIBB : to Announce Results for First Quarter 2015 on April 28
03/27 BRISTOL MYERS SQUIBB : Acquires Exclusive License from Novo Nordisk
03/27 U.S. biotech stocks may fall further as short interest rises
03/26 ALBANY MOLECULAR RESEARCH : Bristol-Myers Squibb Assigned Patent
03/25 BRISTOL MYERS SQUIBB : Recent Findings from Bristol-Myers Squibb Provides New In..
03/25 BRISTOL MYERS SQUIBB : Researchers at Bristol-Myers Squibb Release New Data on L..
03/25 BRISTOL MYERS SQUIBB : New General Science Study Findings Have Been Reported by ..
03/25 BRISTOL MYERS SQUIBB : Trademark Application for "PREGESTIMIL" Filed by Bristol-..
Advertisement
Chart
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF